Plasma Assay of Cell-Free Methylated DNA Markers of Colorectal Cancer: A Tumor-Agnostic Approach to Monitor Recurrence and Response to Anticancer Therapies
Background: Radiographic surveillance of colorectal cancer (CRC) after curative-intent therapy is costly and unreliable. Methylated DNA markers (MDMs) detected primary CRC and metastatic recurrence with high sensitivity and specificity in cross-sectional studies. This study evaluated using serial MD...
Main Authors: | Mojun Zhu, William R. Taylor, Douglas W. Mahoney, Sara S. Then, Calise K. Berger, Kelli N. Burger, Anna M. Gonser, Karen A. Doering, Hao Xie, Patrick H. Foote, Michael W. Kaiser, Hatim T. Allawi, Joleen M. Hubbard, John B. Kisiel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/24/5778 |
Similar Items
-
Different Body Fluid Biopsies for Detecting Minimal Residual Disease in Lung Cancer: a Review of the Latest Advances
by: YAN Xing, LIU Shanmei, LIU Changhong
Published: (2023-01-01) -
The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management
by: Corinna Keup, et al.
Published: (2023-11-01) -
Results of Excision of Unknown Papillary Neoplasms Detected on Core Biopsy
by: Ayşe Nur Uğur Kılınç, et al.
Published: (2021-07-01) -
Prediction of pathological stage in prostate cancer through the percentage of involved fragments upon biopsy
by: Marcos F. Dall'oglio, et al.
Published: (2005-10-01) -
Three different techniques for administering analgesia during transrectal ultrasound-guided prostate biopsy: a comparative study
by: Volkan Izol, et al.
Published: (2012-02-01)